Big Data in Pharmaceuticals – Thematic Research

Pages: 51 Published: March 31, 2022 Report Code: GDHCHT316

  • Overview
  • Key Players
  • Contents
  • Tables
  • Figures
  • FAQ
  • Listen
    iSpeech.org

The global data and analytics market in the pharma sector was valued at $1.4 billion in 2020. The healthcare and pharmaceutical industries generate data in abundance from a multitude of sources including physician notes, pathology reports, electronic health records (EHR), patient registries, genomics, clinical trials, social media, wearable devices, and many more. The dataset in question is huge in both size and complexity, rendering traditional data management techniques inefficient for processing.

This big data in pharmaceuticals – thematic research report assesses how big data analytics, combined with other emerging technologies, can be used across the pharma value chain. It provides an overview of the current landscape, including healthcare, technology, regulatory, and macroeconomic trends, as well as key players, while also highlighting opportunities for the use of big data analytics in the future. Moreover, the report provides an analysis of big data-related deals, jobs, and social media activity, highlighting the impact of the COVID-19 pandemic, where relevant.

Big data and analytics market overview for pharma industry

Big data and analytics market overview for pharma industry

For more insights on this report, download a free report sample

What are the key trends that will shape the big data space?

The key trends that will shape the big data space can be divided into four categories: healthcare trends, technology trends, regulatory trends, and macroeconomic trends.

Healthcare trends

The main healthcare trends that will impact the big data space are real-world data, the COVID-19 pandemic, clinical trial design & recruitment, increased use of digital technologies in clinical research, use of AI and big data in drug discovery, drug repurposing, & vaccine development, precision & personalized medicine, industry 4.0, wearables & the collection of health data, and sales & marketing.

Technology trends

Some of the main technology trends that will impact the big data space are cloud computing, 5G, and cybersecurity.

Regulatory trends

The main regulatory trends that will impact the big data space are data privacy & regulatory compliance, cures 2.0, and partnership with regulatory agencies.

Macroeconomic trends

The main macroeconomic trends that will impact the big data space are cost & rising healthcare demand, drug pricing, and the future of work.

What are the different big data value chains in the pharma industry?

The big data value chains in the pharma industry can be divided into three segments: big data generation, big data management, and big data product development.

Big data generation

In healthcare, data is primarily generated by sources such as hospitals, medical groups, and registries. This data is typically generated in the form of EHRs, which include patient health information such as administrative and billing data, demographics, vital signs, and medical history. Internally, the pharma industry can also generate copious amounts of data from clinical trials as well as from operations such as sales and manufacturing.

Big data management

Big data is typically managed in data centers, either in the public cloud, in corporate data centers, or on end devices. Broadly speaking, the objective of big data management is to secure the data (using data governance and security technology), gather insights from the data (using data analysis and business intelligence tools), and manage the data (by applying storage, processing, aggregation, and integration techniques).

Big data product development

Once the data is stored, processed, secured, and analyzed, it can be used within a raft of big data-powered products. By leveraging the wealth of molecular, clinical, and genomic data available, drug R&D can be optimized in the preclinical and clinical stages of development. From a commercial standpoint, data from registries and sales can inform decision-making on marketing and pricing. Finally, pharmaceutical manufacturing can be optimized with big data and IoT technologies including drones, digital twins, smart sensors, etc.

Who are the key public big data vendors in the pharma industry?

The key public big data vendors in the pharma industry are Amazon, International Business Machines, Microsoft, Oracle, and SAP SE.

Who are the key private big data vendors in the pharma industry?

The key private big data vendors in the pharma industry are Antidote Technologies, BenevolentAI, Deep Genomics, Deep Lens, Exscientia, Healx, Insilico Medicine, Lantern Pharma, and Medidata Solutions.

Market report scope

Market size (Year – 2020) $1.4 billion
Forecast period 2021-2025
Key trends Healthcare Trends, Technology Trends, Regulatory Trends, and Macroeconomic Trends
Value chains Big Data Generation, Big Data Management, and Big Data Product Development
Key public big data vendors Amazon, International Business Machines, Microsoft, Oracle, and SAP SE
Key private big data vendors Antidote Technologies, BenevolentAI, Deep Genomics, Deep Lens, Exscientia, Healx, Insilico Medicine, Lantern Pharma, and Medidata Solutions

Scope

  • Overview of the current and future use cases of big data analytics in the pharma industry, across the value chain.
  • Insightful review of the healthcare, technology, regulatory, and macroeconomic trends. Each trend is independently researched to provide a qualitative analysis of its implications in the big data space.
  • Reports of the revenue opportunity forecast in the data and analytical markets in the pharma industry from 2020 to 2025, spanning three technology segments and 49 geographical markets.
  • Key players in the big data space, with a focus on technology providers and pharma adopters.
  • Industry analysis of big data in the context of jobs in the pharma industry, use of real-world evidence in post-marketing studies, social media, and several pharma-specific case studies.
  • Deals analysis: outline of key deals within the big data space over the past three years, including mergers and acquisitions, strategic partnerships, and funding.

Reasons to Buy

  • Assess who the leading technology players are in the big data space, as well as leading pharma adopters.
  • See examples of how pharma companies are integrating big data analytics into their value chains.
  • Understand what trends are driving the big data space and challenges that exist for pharma in the space.
  • See how the big data landscape is evolving, with a review of company activity including mergers and acquisitions (M&A), strategic partnerships, and funding deals, as well as job analysis.
  • Assess the impact of COVID-19 on big data analytics.

Key Players

Amazon

AstraZeneca

BenevolentAI

Dell Technologies

Dassault Systèmes

Eli Lilly

Exscientia

Google

GlaxoSmithKline (GSK)

Hoffmann-La Roche

International Business Machines (IBM)

Informatica

Insilico Medicine

Johnson & Johnson (J&J)

Microsoft

Medidata

Owkin

Pfizer

Sensyne Health

Unlearn.AI

Table of Contents

Executive Summary

Players

Thematic Briefing

Trends

Healthcare Trends

Technology Trends

Regulatory Trends

Macroeconomic Trends

Value Chain

Big Data Generation

Big Data Management

Big Data Product Development

Industry Analysis

Market Forecast Size

Survey Data

GlobalData’s Digital Transformation and Emerging Technology in the Healthcare Industry Survey, 2021

GlobalData’s Smart Pharma Survey 2021

Use of Real-World Evidence in Post-Marketing Studies

Analysis of Big Data-Related Jobs in Pharma

Deals Analysis

Mergers and Acquisitions

Strategic Partnerships

Funding Deals

Pharma Case Studies

Sumitomo Dainippon Pharma and Exscientia: Drug Discovery and Development

Syapse’s Learning Health Network and RWE

Unlearn.AI: DiGenesis, Twintelligent RCTs, and Digital Twins

Infor and Bayer: Infor Enterprise Asset Management and Digital Twins

Evidation and Merck: Digital Monitoring with Focus on Alzheimer’s Disease

Social Media Influencers

Companies

Leading Big Data Vendors

Specialist Big Data Vendors in Pharma

Leading Big Data Adopters In Pharma

Appendix

Abbreviations

Further Reading

Related Reports

Bibliography

About the Authors

Healthcare Analyst

Managing Analyst

Director of Thematic Analysis

Global Head and EVP of Healthcare Operations and Strategy

| Our Thematic Research Methodology

| About GlobalData

| Contact Us

List of Tables

Table 1: Healthcare trends in the big data space

Table 2: Technology trends in the big data space

Table 3: Regulatory trends in the big data space

Table 4: Macroeconomic trends in the big data space

Table 5: Examples of M&A in the big data and pharma spaces, 2019–2022

Table 6: Examples of strategic partnerships in the pharma big data space, 2021

Table 7: Examples of large funding deals in the big data space since Q2 2020

Table 8: Examples of public big data vendors in pharma

Table 9: Examples of private big data vendors in pharma

Table 10: Examples of leading big data adopters in pharma

List of Figures

Figure 1: Who are the leading players in the big data in the pharma space?

Figure 2: Big data value chain in pharma

Figure 3: Pharma contributed 1.7% to the total global data and analytics market in 2020

Figure 4: Pharma will contribute 1.5% to the total global data and analytics market in 2025

Figure 5: The total global data and analytics market for pharma was valued at $1.4B in 2020, led by the US

Figure 6: The US will dominant the global data and analytics market in pharma in 2025

Figure 7: Technologies that pharma is prioritizing for current investments

Figure 8: The most disruptive technologies in the upcoming two years

Figure 9: The benefits of integrating smart technologies into the pharmaceutical industry by company size

Figure 10: Big data is important and could optimize many processes in the pharmaceutical industry

Figure 11: Future usage of big data analytics for drug discovery and development will remain the same

Figure 12: Pharma will use both in-house capabilities and vendors for big data analytics

Figure 13: Impact of the COVID-19 pandemic on investment in big data

Figure 14: Top pharma sponsors of clinical trials with an RWE element

Figure 15: Oncology is the leading therapy area for clinical trials related to RWE

Figure 16: Examples of pharma companies posting jobs related to big data

Figure 17: Trends in big data-related job posting by pharma, 2019–2022

Figure 18: Big data trends in GlobalData’s social media analytics database, March 2021–March 2022

Figure 19: Examples of Top Posts Related to Big Data, 2021–2022

Frequently Asked Questions

The global data and analytics market for pharma industry was valued at $1.4 billion in 2020.

 

 

 

 

The key trends that will shape the big data space can be divided into four categories: healthcare trends, technology trends, regulatory trends, and macroeconomic trends.

The big data value chains in the pharma industry can be divided into three segments: big data generation, big data management, and big data product development.

The key public big data vendors in the pharma industry are Amazon, International Business Machines, Microsoft, Oracle, and SAP SE.

The key private big data vendors in the pharma industry are Antidote Technologies, BenevolentAI, Deep Genomics, Deep Lens, Exscientia, Healx, Insilico Medicine, Lantern Pharma, and Medidata Solutions.

$1950

Can be used by individual purchaser only

$3900

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.